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A B s T r A C T
Background: Patients with proteinuria may suffer from 
substantial losses of functional proteins such as hormones 
and hormone-binding proteins. A limited number of 
studies have reported urinary losses of thyroid hormones 
and thyroxin-binding globulin. overt hypothyroidism 
attributable to these urinary losses has been described. 
However, the impact of proteinuria on thyroid function 
parameters has not been studied in a large patient cohort. 
Methods: We evaluated thyroid function parameters in 
patients with proteinurea who are negative to thyroxine 
peroxidase antibodies (TPoAbs). Values of free thyroxin 
and thyroid-stimulating hormone (TsH) were compared 
with data from age- and gender-matched controls derived 
from the Nijmegen Biomedical study, a population-based 
survey conducted in our hospital. 
results: We evaluated 159 patients. There were 111 males 
and 48 females. Median (iQr) age was 52 (40 to 62) 
years, serum creatinine concentration 99 (82 to 134) 
µmol/l, serum albumin concentration 29 (22 to 35) g/l, and 
proteinuria 6.6 (3.1 to 10.9) g/10 mmol creatinine. Median 
TsH was significantly higher in the patients than the 
controls (1.81 mU/l vs 1.34 mU/l, p<0.0001). in the patients, 
TsH was negatively correlated with serum albumin (r=-0.21; 
p<0.01). subclinical hypothyroidism was six times more 
frequent in the patients (11.3 vs 1.8%, p<0.001); however, 
overt hypothyroidism was observed in only one patient. 
Conclusion: Patients with proteinuria have higher TsH 
levels, consistent with urinary loss of thyroid hormones. 
However, these urinary losses do not result in overt, 
clinically relevant, hypothyroidism. The role of subclinical 
hypothyroidism in these patients needs further 
evaluation.
K E Y W o r d s
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i N T r o d U C T i o N
Proteinuria is a hallmark of renal diseases. Severe proteinuria 
results in the nephrotic syndrome, which is characterised by 
proteinuria, hypoalbuminaemia, oedema and hyperlipidaemia. 
Albumin is the most abundant protein in serum and urine. In 
patients with a nephrotic syndrome urinary losses of albumin 
are not fully compensated by the increased hepatic production, 
with hypoalbuminaemia as a consequence. In patients with 
proteinuria many other proteins beside albumin are lost in 
the urine. Among these are hormones and hormone-binding 
proteins. Several studies have documented urinary loss of 
thyroid hormones and thyroxin-binding globulin (TBG) in 
patients with proteinuria.1-4 The clinical relevance of this is 
unknown. The abovementioned studies included a limited 
number of patients (in total 49 patients in four studies). In 
one study overt hypothyroidism was noted in two patients that 
resolved after remission of the nephrotic syndrome.3 
In patients with the nephrotic syndrome, loss of thyroid 
hormones may lead to low free thyroid hormone levels unless 
production is increased under the influence of thyroid-
stimulating hormone (TSH). Furthermore, loss of albumin 
and TBG may reduce the binding capacity for thyroid 
hormones, resulting in a decrease in total triiodothyronine 
(T3) and thyroxin (T4) concentrations. 
Thus far no study has systematically evaluated thyroid 
hormone status in patients with proteinuria. We have 
analysed thyroid function in a large cohort of patients with 
proteinuria.
For comparison we have used data obtained in the Nijmegen 
Biomedical Study, a population-based study in our hospital.5 
s U B J E C T s  A N d  M E T H o d s
In our centre patients with proteinuria are evaluated 
using a standard protocol.6 In brief, patients are seen 
after an overnight fast. Blood pressure and bodyweight 
are measured and serum and urine samples are collected 
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for measurement of creatinine and albumin. In addition 
aliquots of serum are stored at -70oC. 
For the current study we thawed frozen samples obtained 
from 200 consecutive patients studied in the period 
2001-2004.
laboratory methods
In the serum of the patients, TSH, T4, free thyroxin 
(FT4), T3 and thyroxine peroxidase antibodies (TPOAbs) 
were measured. TSH, FT4 and TPOAbs were measured 
as described.5 For the measurement of FT4 an incubation 
buffer was used without a physiological concentration of 
chloride. Since chloride primarily affects T4 binding to 
albumin, a slight artefact (a decrease of 10 g/l in serum 
albumin causes apparent increase of FT4 by about 0.5 
pmol/l) results that is normally negligible, but must be 
taken into account with moderate to severe hypoalbu-
minaemia. To correct for this in vitro artefact we used the 
following formula: corrected FT4 = FT4 + (0.0542 x (serum 
albumin - 46). Total T4 and T3 were measured by means of 
a Luminometric immunoassay performed on an Architect 
immunoanalyser (Abbott Diagnostics, Amstelveen, the 
Netherlands). Within- and between-assay CVs were: for T4 
3.8 and 6.5% at a level of 46 nmol/l, 3.6 and 5.1% at 108 
nmol/l and 4.2 and 10.8 at 194 nmol/l respectively; for T3 
3.5 and 5.4% at 1.05 nmol/l, 2.8 and 4.3% at 1.68 nmol/l and 
2.5 and 3.3% at 6.0 nmol/l. The reference range for T4 is 55 
to 155 nmol/l and for T3 1.2 to 2.9 nmol/l. For TPOAbs we 
used a cut-off value of <12 kU/l to define TPOAbs-negative 
patients as described.5 Serum and urine creatinine, and 
albumin, were measured by standard techniques.6
data analysis
Data of the patients were compared with data from an 
age- and sex-matched control group derived from the 
Nijmegen Biomedical Study. The Nijmegen Biomedical 
Study (NBS) is a population-based survey conducted by 
the Department of Epidemiology and Biostatistics and the 
Department of Clinical Chemistry of the Radboud University 
Nijmegen Medical Centre. A total of 21,757 age and sex 
stratified randomly selected inhabitants of the municipality 
of Nijmegen received an invitation to fill out a postal 
questionnaire on lifestyle and medical history, and to donate 
an 8.5 ml blood sample in a serum separator tube and a 
10 ml ethylenediaminetetraacetic acid (EDTA) blood sample. 
The response to the questionnaire was 43% (n=9371). Of the 
responders, 69% (n=6473) donated blood samples.5 In these 
blood samples FT4 and TSH were measured.
For the present study matched controls were selected 
from the NBS database, in a ratio of one (patient) to five 
(controls) using age and gender as matching criterion. 
Glomerular filtration rate (GFR) was estimated using the 
modification of diet in renal disease (MDRD) formula.7 We 
used the original formula eGFR(ml/min/1,73 m2) = 170 x 
(serum creatinine x 0.0113)-0.999 x (age)-0.176 x (serum urea x 
2.8)-0.170 x (serum albumin/10)+0.318 x 0.762 (if female) x 1.18 
(if black), where serum creatinine in µmol/l, serum urea in 
mmol/l and serum albumin in g/l. 
Statistical analysis was performed using the Mann-Whitney 
U test for comparison between patients and controls. 
Pearson’s correlation coefficient was used as a parameter 
for correlation between thyroid parameters and serum 
albumin concentration or eGFR. For TSH log transformed 
values were used because of the skewed distribution. P 
values <0.05 were considered statistically significant. 
r E s U l T s
We studied 200 patients with a renal disease and 
proteinuria. For comparison we selected 1000 age- 
and gender-matched controls. Sera of 41 patients and 
100 controls were positive for TPOAbs. In view of the 
well-known relationship between positive anti-TPOAbs 
and hypothyroidism, we have limited the analysis to 
TPOAbs-negative patients and controls. Clinical 
characteristics are presented in table 1. Proteinuria values 
in our patients were 6.6 (3.1-10.9) g/10 mmol creatinine. 
Overall TSH was significantly higher in the patients. 
There were no differences in FT4 values. In the patients 
total T4 concentration was 90 (IQR 78-103) nmol/l 
and total T3 concentration 1.99 (IQR 1.72-2.27) nmol/l. 
These parameters were not measured in our matched 
Table 1. Baseline characteristics and thyroid hormone 
status of patients and controls
Proteinuria Proteinuria vs 
control
Control
Age (years)
Sex (male/
female)
Albumin (g/l)
Creatinine 
(µmol/l)
TSH (mU/l)
FT4 (pmol/l)
Anti-TPO (mU/l)
Overt 
hyperthyroidism
Subclinical 
hyperthyroidism
Euthyroid
Overt 
hypothyroidism
Subclinical 
hypothyroidism
Undefined
52 (40-64)
111/48
29 (22-35)
99 (82-134)
1.81 (1.04-2.81)
13.1 (11.4-14.8)
5.7 (4.2-7.8)
 
0 (0%)
1 (0.6%)
133 (83.6%)
1 (0.6%)
18 (11.3%)
6 (3.8%)
p<0.0001
p<0.0001
p<0.0001
p<0.01
p<0.001
52 (40-64)
642/258
46 (44-48)
83 (76-92)
1.34 (0.98-1.87)
13.1 (11.9-14.5)
5.1 (4.3-6.1)
2 (0.2%)
0 (0%)
877 (97.4%)
0 (0%)
16 (1.8%)
5 (0.6%)
data are for TPoAbs-negative subjects. Values are given as median 
(iQr). Hyperthyroidism was classified as overt if TsH was <0.1 mU/l 
and fT4 >22 pmol/l and as subclinical if TsH was <0.1 mU/l and 
fT4 ≤22 pmol/l. Hypothyroidism was classified as overt if TsH was 
>4 mU/l and fT4 <8.0 pmol/l and as subclinical if TsH was >4 mU/l 
and fT4 ≥8 pmol/l. definitions according to Hoogendoorn et al.5
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control population of the Nijmegen Biomedical Study. For 
comparison, normal values as used in our laboratory are 55 
to 155 nmol/l for total T4 and 1.2 to 2.9 nmol/l for total T3. 
Subclinical hypothyroidism was six times more frequent 
in the patients than in the controls (table 1). Of note, overt 
hypothyroidism was observed in only one patient. 
In the patients TSH was negatively correlated with serum 
albumin (r=-0.21; p<0.001; figure 1). TSH was not correlated 
with eGFR (r=0.05). Total T4 correlated with eGFR (r=0.16, 
p<0.05), not with serum albumin concentration (r=0.125). 
FT4 did not correlate with eGFR (r=-0.09). We observed 
significant correlations between T3 and eGFR (r=0.26; 
p<0.01) and T3 and serum albumin (r=0.36; p<0.001). 
d i s C U s s i o N
Our study demonstrates that abnormalities in thyroid 
function occur in patients with proteinuria. Specifically, TSH 
levels were higher in patients with proteinuric renal diseases 
when compared with age- and sex-matched controls. These 
data are consistent with the reports of urinary losses of 
thyroid hormones in patients with proteinuria.1-4 Apparently, 
these urinary losses of thyroid hormones in patients with 
proteinuria result in a stimulation of TSH production. 
The role of proteinuria is confirmed by the significant and 
negative correlation between TSH and serum albumin.
Although one study described the development of overt 
hypothyroidism in patients with a nephrotic syndrome, the 
prevalence of this complication has remained unclear.3 
Subclinical hypothyroidism occurred more frequently in 
our patients and we observed overt hypothyroidism in only 
one of 159 patients. Figure 1 clearly illustrates that even in 
patients with the most severe nephrotic syndrome, TSH 
levels did not often exceed 4 mU/l.
We noted a correlation between total T4 and T3 and eGFR. 
In a recent study Lo et al. evaluated thyroid function in 
relation to renal insufficiency.8 These authors noted an 
increased prevalence of hypothyroidism, as defined by 
increased TSH levels, in patients with decreased GFR. 
Unfortunately, FT4 and proteinuria were not measured by 
Lo and colleagues. Our data suggest that both proteinuria 
and GFR influence the activity of the pituitary-thyroid 
axis. Proteinuria results in loss of thyroid hormones, most 
probably caused by loss of thyroxin-binding globulin, thus 
stimulating TSH production. 
In view of the well-known relation between TPOAbs and 
hypothyroidism, we excluded TPOAbs-positive patients 
and controls from the final data analysis. However, even 
when considering all patients, overt hypothyroidism was 
observed in only one patient. The prevalence of TPOAbs 
positivity was similar in patients and controls. There is one 
caveat. Since TPOAbs could have been lost in the urine, 
the usual criteria for discerning between TPOAbs-positive 
and -negative persons might not fully apply to patients with 
proteinuria. Of note, there was no correlation between 
TPOAbs titre and serum albumin.
C o N C l U s i o N
Our study shows that TSH is elevated in patients with 
proteinuria. However, the clinical relevance of this finding 
is limited since overt hypothyroidism was present in less 
than 1% of the patients. 
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figure 1. Correlation of thyroid-stimulating hormone 
and serum albumin concentration in patients with 
proteinuria
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only patients without anti-TPo antibodies were included in this 
analysis (r=-0.21; p=0.01).
